Coronavirus disproportionally affects vulnerable populations including older people and those with chronic diseases such as diabetes, and heart and lung disease. Every year, these same individuals are most impacted by seasonal influenza, with CDC estimates suggesting that 70-85% of influenza related deaths have occurred among people aged 65 years and older. Where death is not the result, influenza can lead to hospitalizations, long standing diminished function as well as acute or long-term complications.
A recent Vaccines Today article written by IFA Expert Mr. Gary Finnegan, Editor of Vaccines Today, explains that although a coronavirus vaccine will not be available for the winter of 2020/2021, vaccines are available that protect against influenza. Mr Finnegan goes on to explain that despite this “every year, huge numbers of people who should be vaccinated are not.” The public often underestimates the impact of influenza on the individual and their family; as well as health and social care systems.
Vaccinations against diseases such as influenza have been proven to effectively reduce the risk of adverse consequences for adults with chronic diseases and prevent decline in functional ability of older people. A life course approach to vaccination is therefore critical to healthy ageing. Secretary General of IFA, Dr Jane Barratt adds to this point: “We need to look at flu vaccination rates, but also immunization against pneumococcal disease and shingles. Many of the same people suffering the worst of the COVID-19 outbreak are also those who would benefit from these vaccines.”
It is for these reasons that IFA, for over 9 years now, has been advocating for a life course approach to vaccination, with focus on at-risk groups. IFA’s work on vaccination, Vaccines4Life, is set within the context of the WHO Decade of Healthy Ageing, and is aligned with the WHO Immunization Agenda 2030. Under this portfolio of work, IFA envisions a world of healthy older people whose rights to safe and appropriate vaccines are respected through programs that hold high the principles of prevention, access and equity.
Removing barriers impeding access to vaccination such as cost and complex vaccination pathways are critical to ensuring people of all ages are protected and no one is left behind. One way influenza vaccination rates could be improved is through pharmacists as a vaccinator gateway.
In countries such as Portugal, Switzerland, Norway and the United Kingdom, pharmacists are able to administer vaccinations if they complete the required training. This can allow for greater reach to at-risk groups such as older people who may not typically go out of their way to be vaccinated by their doctor. The pharmacist-vaccinator gateway is important for not only influenza season, but also could be useful when a COVID-19 vaccine is released.
Do you have an interesting article, video, webinar or podcast that speaks to improving vaccination rates for at-risk groups? Submit your document to the new IFA VacciNet database to share this important knowledge, and reach out to IFA experts Mr Finnegan and Dr Barratt for further comments on the topic area. To learn more on the interrelationship between COVID-19 and other age-related matters (including grandparenting, technology and ageism) visit IFA’s COVID-19 resource library.
Emily A. Greenfield, Ph.D.
Life Course Human Development
Social Relationships and Health
Doug Earle, CFRE
Inherited Retinal Diseases
COVID-19's impact on vision loss
Prof. Nigel Harris
Technology for people living with Dementia
Dr. Endre Ludwig
Dr. Fiona Aspinal
Palliative Care Provision and Quality